|4Mar 1, 9:58 PM ET

Ek John Frederick 4

4 · Akoya Biosciences, Inc. · Filed Mar 1, 2024

Insider Transaction Report

Form 4
Period: 2024-02-22
Transactions
  • Award

    Common Stock

    2024-02-22+35,000195,000 total
  • Award

    Employee Stock Option (Right to Buy)

    2024-02-22+70,00070,000 total
    Exercise: $5.35Exp: 2034-02-22Common Stock (70,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    20,000
Footnotes (3)
  • [F1]The restricted stock units shall vest in four (4) equal annual installments beginning on March 1, 2025, and annually thereafter until fully vested.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
  • [F3]The options shall vest as follows: twenty-five percent (25%) shall vest on February 22, 2025 with the remainder vesting in 36 equal monthly installments beginning on March 22, 2025.

Documents

1 file
  • 4
    tm247817-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT